Key probe compositions and methods for polynucleotide detection

Details for Australian Patent Application No. 2006213907 (hide)

Owner Stratagene California

Inventors Firmin, Andrew; Happe, Scott; Sorge, Joseph A.

Agent Smoorenburg Patent and Trademark Attorneys

Pub. Number AU-A-2006213907

PCT Pub. Number WO2006/086502

Priority 60/688,798 09.06.05 US; 60/748,267 07.12.05 US; 60/665,400 25.03.05 US; 60/651,310 09.02.05 US

Filing date 9 February 2006

Wipo publication date 17 August 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/086502 Priority application(s): WO2006/086502

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213915-Medical devices

2006213894-Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses